The EU-funded POTENT project has been developing a new type of drug delivery system for glioblastoma, an aggressive form of brain cancer. It can considerably improve treatment outcomes for patients and increase their life expectancy. Clinical trials could start in 2 to 4 years, a step closer to making the system available for the patients that could most benefit from it.
Drug assessment for potential negative effects on patients’ hearts is a cost-intensive task, and it still occasionally fails to deliver on its promise. The EU-funded MAREP project has created a new laser-based technology that can streamline the drug development process. At the same time, it enhances patient safety which is a big plus for all citizens.
The EU-funded DEBUNKER project has been studying the mechanisms creating, reinforcing and correcting
Whilst being a renewable energy, hydropower has a rather large environmental footprint. From its
Even though Neanderthals once dominated Eurasia, we know very little about how they lived and why
The ancient Egyptians left behind a plethora of papyri containing valuable written information but